Menu

Humana Reports 3RD Quarter 2016 Financial Results

AddThis Social Bookmark Button
  • 3Q 2016 earnings per share (EPS) of $2.98 on a GAAP basis, Adjusted EPS of $3.18
  • Full-year 2016 earnings per share guidance of approximately $8.68 on a GAAP basis; Adjusted EPS guidance of approximately $9.50 reiterated
  • Medicare Advantage and Healthcare Services businesses performing above expectations
  • Individual commercial and Group segment performance in line with management’s expectations
  • 3Q 2016 cash flows from operations of $4.50 billion on a GAAP basis, $1.47 billion on an Adjusted basis versus 3Q 2015 cash flows from operations of $1.03 billion (both GAAP and Adjusted)

“We are pleased that our third-quarter results enable us to reaffirm our recently-raised EPS guidance for 2016, which includes two meaningful guidance increases during the course of the year,” said Brian A. Kane, Senior Vice President and Chief Financial Officer for Humana. “These increases are largely attributable to our better-than-expected performance in Medicare Advantage and Healthcare Services and we believe our performance positions us well for 2017.”

“We continue to meet or exceed our initial 2016 earnings expectations across our portfolio of businesses, with the exception of our individual commercial business,” said Bruce D. Broussard, Humana’s President and Chief Executive Officer. “We attribute this over-performance to the effectiveness of our clinical programs and management’s top priority of operational execution notwithstanding the elongated regulatory review of the Aetna transaction.”

 

back to top